Tag mtx [21 articles] Export

Recent papers classified by the tag mtx.

	A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of beta-catenin/GSK3 signaling. [My Copy] PloS one, Vol. 4, No. 9. (2009) by Richard A. Klinghoffer, Jason Frazier, James Annis, et al.Jason D. Berndt, Brian S. Roberts, William T. Arthur, Raul Lacson, Xiaohua Douglas D. Zhang, Marc Ferrer, Randall T. Moon, Michele A. Cleary posted to pbmc mtx gsk3 dhfr catenin by guhjy on 2009-09-06 10:08:05 as
	Identification of AML1-ETO modulators by chemical genomics. [My Copy] Blood, Vol. 113, No. 24. (11 June 2009), pp. 6193-6205. by Steven M. Corsello, Giovanni Roti, Kenneth N. Ross, et al.Kwan T. Chow, Ilene Galinsky, Daniel J. DeAngelo, Richard M. Stone, Andrew L. Kung, Todd R. Golub, Kimberly Stegmaier posted to u937 steroids mtx methotrexate kasumi-1 eto corticosteroids aml1-eto aml1 by smop on 2009-08-29 13:21:26 as
	Secretion of genetically-engineered dihydrofolate reductase from Escherichia coli using an E. coli alpha-hemolysin membrane translocation system. [My Copy] Applied microbiology and biotechnology, Vol. 37, No. 6. (September 1992), pp. 765-771. by H. Nakano, Y. Kawakami, H. Nishimura posted to 4grant dhfr hemolysin hlyb mtx type-i by martainn on 2009-04-23 17:07:45 as
	Yop fusions to tightly folded protein domains and their effects on Yersinia enterocolitica type III secretion. [My Copy] Journal of bacteriology, Vol. 184, No. 13. (July 2002), pp. 3740-3745. by V. T. Lee, O. Schneewind posted to 4grant dhfr mtx type-iii yersinia by martainn on 2009-04-23 17:03:27 as
	Yersinia enterocolitica type III secretion: evidence for the ability to transport proteins that are folded prior to secretion. [My Copy] BMC microbiology, Vol. 4 (12 July 2004) by G. Wilharm, V. Lehmann, W. Neumayer, J. Trcek, J. Heesemann posted to dhfr fusion mtx type-iii by martainn on 2009-04-23 17:00:34 as
	Resistance to methotrexate due to AcrAB-dependent export from Escherichia coli. [My Copy] Antimicrobial agents and chemotherapy, Vol. 44, No. 11. (November 2000), pp. 3210-3212. by S. J. Kopytek, J. C. Dyer, G. S. Knapp, J. C. Hu posted to 4grant dhfr fusion mtx tolc by martainn on 2009-04-23 16:58:31 as
	Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism [My Copy] J Oncol Pharm Pract, Vol. 14, No. 3. (1 September 2008), pp. 153-156. by David C. Gammon, Mansi S. Bhatt, Bhavini Patel, Meghan Anderson, Alixis Van Horn, Michael J. Glantz posted to mthfr mtx snp by eisei on 2009-01-15 02:23:45 as
	Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma [My Copy] J Clin Oncol, Vol. 25, No. 30. (20 October 2007), pp. 4730-4735. by Gaurav D. Shah, Joachim Yahalom, Denise D. Correa, et al.Rose K. Lai, Jeffrey J. Raizer, David Schiff, Renato Larocca, Barbara Grant, Lisa M. Deangelis, Lauren E. Abrey posted to lymphoma mtx pcnsl by eisei on 2008-05-01 13:29:31 as along with 1 person lrust
	Treatment of CNS dissemination in systemic lymphoma [My Copy] Journal of Neuro-Oncology, Vol. 84, No. 1. (August 2007), pp. 107-117. by Gleissner, B., Chamberlain, M. posted to pcnsl lymphoma mtx review by eisei on 2008-05-01 13:27:55 as
	Primäre ZNS-Lymphome des immunkompetenten Patienten [My Copy] Der Onkologe, Vol. 7, No. 9. (2001), pp. 990-997. by A. Korfel, M. Weller, L. Plasswilm, M. Bamberg, E. Thiel posted to pcnsl lymphoma mtx by eisei on 2008-05-01 13:27:15 as
	The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. [My Copy] Ann Rheum Dis, Vol. 67, No. 3. (March 2008), pp. 370-374. by M. Bartoli, M. Tarò, S. Magni-Manzoni, et al.A. Pistorio, F. Traverso, S. Viola, A. Magnani, C. Gasparini, A. Martini, A. Ravelli posted to jia mtx by wizblue on 2008-02-26 07:55:54 as
	Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 16, No. 11. (November 2005), pp. 3326-3338. by Kosuke Yozai, Kenichi Shikata, Motofumi Sasaki, et al.Atsuhiro Tone, Sakiko Ohga, Hitomi Usui, Shinichi Okada, Jun Wada, Ryo Nagase, Daisuke Ogawa, Yasushi Shikata, Hirofumi Makino posted to stz rat nfkb mtx dn dhfr by guhjy on 2008-01-14 15:31:29 as
	Influence of substrate binding on the mechanical stability of mouse dihydrofolate reductase. [My Copy] Biophys J, Vol. 89, No. 5. (November 2005) by J. P. Junker, K. Hell, M. Schlierf, W. Neupert, M. Rief posted to dhfr e22 mtx nadph by FBerkemeier on 2005-11-04 11:14:44 as
	A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing. [My Copy] J Rheumatol, Vol. 20, No. 11. (November 1993), pp. 1845-1849. by J. W. Jundt, B. A. Browne, G. P. Fiocco, A. D. Steele, D. Mock posted to mtx parenteral by rajsen on 2005-05-05 16:02:45 as
	Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis. [My Copy] Arthritis Rheum, Vol. 33, No. 1. (January 1990), pp. 91-94. by P. J. Brooks, W. J. Spruill, R. C. Parish, D. A. Birchmore posted to mtx parenteral by rajsen on 2005-05-05 16:02:11 as
	Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. [My Copy] Br J Rheumatol, Vol. 36, No. 1. (January 1997), pp. 86-90. by R. A. Hamilton, J. M. Kremer posted to mtx parenteral by rajsen on 2005-05-05 16:01:19 as
	Caveats to the use of parenteral methotrexate in the treatment of rheumatic disease. [My Copy] Rheumatology (Oxford), Vol. 44, No. 2. (February 2005), pp. 256-257. by R. K. Moitra, J. M. Ledingham, R. G. Hull, et al.F. C. McCrae, A. L. Thomas, R. Shaban, K. R. Mackay posted to mtx parenteral by rajsen on 2005-05-05 16:00:04 as
	Intramuscular methotrexate in inflammatory rheumatic disease. [My Copy] Ann Rheum Dis, Vol. 60, No. 12. (December 2001) by G. Burbage, R. Gupta, K. Lim posted to mtx parenteral by rajsen on 2005-05-05 15:58:50 as
	Parenteral methotrexate should be given before biological therapy [My Copy] Rheumatology, Vol. 42, No. 8. (August 2003), pp. 1009-1010. by A. Pollard, J. White, S. Bingham, M. Buch, S. Lindsay, P. Emery posted to mtx parenteral by rajsen on 2005-05-05 15:52:20 as
	Is parenteral methotrexate worth trying? [My Copy] Ann Rheum Dis, Vol. 60, No. 4. (April 2001) by A. Osman, D. Mulherin posted to mtx parenteral by rajsen on 2005-05-05 15:49:38 as
	Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: A randomized, controlled trial [My Copy] Arthritis & Rheumatism, Vol. 50, No. 2. (5 February 2004), pp. 364-371. by C. Michael Lambert, Sharron Sandhu, Alison Lochhead, Nigel P. Hurst, Euan Mcrorie, Veena Dhillon posted to mtx parenteral by rajsen on 2005-05-05 15:48:22 as

Note: You may cite this page as: http://www.citeulike.org/tag/mtx

parenteral	8
dhfr	7
4grant	3
lymphoma	3
pcnsl	3
fusion	2
type-iii	2
aml1	1
aml1-eto	1
catenin	1
corticosteroids	1
dn	1
e22	1
eto	1
gsk3	1
hemolysin	1
hlyb	1
jia	1
kasumi-1	1
methotrexate	1
mthfr	1
nadph	1
nfkb	1
pbmc	1
rat	1
review	1
snp	1
steroids	1
stz	1
tolc	1
type-i	1
u937	1
yersinia	1

Tag mtx [21 articles] Export

Related Tags